Displasia tanatófora. Estado actual: a propósito de dos casos
Delgado Carrasco, J; Casanova Morcillo, A; Zabalza Alvillos, MR.
Acta pediatr. esp
; 58(10): 580-585, nov. 2000.
Artigo Es | IBECS (Espanha) | ID: ibc-8788
Documentos relacionados
Collagen X Marker Levels are Decreased in Individuals with Achondroplasia.
Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia.
[Clinical features and <i>FGFR3</i> mutations of children with achondroplasia].
Achondroplasia-First Report from India of a Rare FGFR3 Gene Variant.
Biallelic deep intronic variant c.5457+81T>A in TRIP11 causes loss of function and results in achondrogenesis 1A.
Chromosome 4p16 and osteochondroplasias.
Clinical and molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 (FGFR3) in Portugal.
Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level.
Deeplasia: deep learning for bone age assessment validated on skeletal dysplasias.
Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies.